Skip to content

Physiologic Adaptations to Interval and Continuous Running at Low Volume and Vigorous Intensity Over 14-Weeks.

Physiological Responses to Constant-load (Continuous) vs. Variable-intensity (Interval) During 14 Weeks of Supervised Aerobic Exercise on Active Men.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01816451
Enrollment
35
Registered
2013-03-22
Start date
2012-03-31
Completion date
2012-12-31
Last updated
2014-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exhaustion - Physiological

Keywords

aerobic capacity, cardiorespiratory training, blood lactate concentration, heart rate

Brief summary

The purpose of this study was to verify physiological responses to constant-load (continuous) vs. variable-intensity (interval) during 14 weeks of aerobic exercise on active men. The hypothesis was that would be differences in physiological variables on distinct modes of execution performed on the treadmill over a period of 14 weeks of training.

Detailed description

Initially there were thirty five subjects, but due factors outside the present study, three individuals were excluded from the program. Two individuals during maximal exercise test (VO2) showed clinical impairment test being interrupted by the doctor and the third individual presented a plantar fasciitis in the early familiarization. Thirty two healthy and active males volunteered to participate in the study. All subjects exercised habitually, with at least 1 year experience aerobic training. The Human Ethics Committee of Rio de Janeiro Federal University approved this study (no 58659/02471312.8.0000.5257).The subjects performed a total of nine visits to the laboratory of the Brazilian Navy at City of Rio de Janeiro for physical tests on different days, except between visits I-II and VII-III. The interval between visits was one week between visits II-III-IV and VIII-IX, six weeks between the first day of training and visits V, four weeks between V-VI-VIII. All subjects from interval and continuous groups performed a total of 46 sessions of supervised running program.

Interventions

The present study was designed to compare the physiological effects between the two training regimes and the control group.The subjects from interval and continuous group performed others activities as resistance training, swimming or soccer. Those activities wasn't controlled by our study, but the individual didn't do physical activities at least 3 hours before started our running sessions. The control group simply performed their normal physical activities (resistance training, swimming or soccer). But, each 3 weeks we had a contact with control group to check about any injury or illness that could affect the final results. None were found.

Sponsors

University of Trás-os-Montes and Alto Douro
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
25 Years to 32 Years
Healthy volunteers
No

Inclusion criteria

* self reporting no contraindication to high-intensity exercise. * physically active on cardiorespiratory activities in a regular basis for at least six months. * presence of negative responses on all items of the Questionnaire of Physical Activity Readiness (PAR-Q Test).

Exclusion criteria

* make use of medication that may interfere with the results, especially inhibitors appetites and dietary supplements. * presence of joint problems that prevents the achievement of training. * presence of disorders such as diabetes, dyslipidemia and anemia * have performed intense exercise with lowers members before the training sessions.

Design outcomes

Primary

MeasureTime frameDescription
Fat Mass (%)Pre and post 14 weeks/46 sessions of trainingThe subjects underwent a set of anthropometric assessments, which followed the norms of the International Society for Advancement of Kinanthropometry. The fat mass was calculated by percentage using the equation proposed by Jackson and Pollock (1978) from seven skinfold measurement. To measure the skinfolds, a Sanny Professional Skinfold Caliper was used.
Heart Rate on Maximal TestPre and post 14 weeks at rest (5 min sitting; before start the test), during the test (to determine max), and 60s and 120s immediately after the end of the test (on sitting position)The HR was collected pre and post training on maximal VO2 test. Initially, with the individual on the treadmill (Inbrasport Master Super, Porto Alegre, Brazil), electrodes (Micromed) were placed at the manubrium, right and left iliac crest for measured heart rate (HR) (derivation CM5) and were connected to an electromyography equipment (Micromed®). HR values were visualized through Elite software (Micromed Biotechnology, Brasilia, Brazil).
Blood Lactate Concentrations on Maximal TestPre and post 14 weeks/46sessions on rest (5 min sitting position; before start the test); 1-3-5 min immediately after the end of the test (on sitting position).Capillary blood samples (25 µl) were obtained from the finger of each subject during all tests and the \[La\] were measured using an (Accutrend®Plus Roche Diagnostics Gesellschaft mit beschränkter Haftung , Mannheim, Germany). The measuring range was 0.8-22 millimole (mM). The sample is collecting (Accu-Chek® Softclix) and first applied to a coded yellow test strip (Accutrend Blood measure-Roche) with a reagent chemical substance. Blood was added to the strip by letting it drip from a finger; in accordance with the instrument's instructions. The finger never touched the strip's pad in order to exclude any possible interference due to the sweat. All \[La\] were collected by a single, experienced investigator.
Body Mass (BM)Body Mass was collected pre and post trainingTo measure body mass Filizola scales with a stadiometer was used.
Rate of Perceived Exertion (RPE) on Maximal TestPre and post 14 weeks/46 sessions of trainingThe RPE was collected at maximal test (see description of test on outcome measure Maximal Oxygen Uptake). Relative to overall feelings were collected by Category Ratio Scale (CR10) during the last 15 s of each stage using the Borg category (0 - 10) scale. Instructions for RPE were that 0 corresponds to rest, and 9 - 10 corresponds to maximal exertion. This verbal procedure was explained before initiating exercise.
Relative Maximal Oxygen UptakePre and post 14 weeksThe relative maximal oxygen uptake was taken by individual connected to a metabolic gas analyzer (VO-2000, Aerosport, Medgraphics, St. Paul, Minnesota) through which the gas samples were collected and measured each 10 seconds during the test. The participants were submitted to a ramp protocol with an initial velocity of 8.0 km/h (0% of inclination), progressive increments, a final velocity of 18 km/h (2% de inclination). The duration was equal to 10 minutes or until voluntary exhaustion.
Absolute Maximal Oxygen UptakePre and post 14 weeksThe absolute maximal oxygen uptake was taken by individual connected to a metabolic gas analyzer (VO-2000, Aerosport, Medgraphics, St. Paul, Minnesota) through which the gas samples were collected and measured each 10 seconds during the test. The participants were submitted to a ramp protocol with an initial velocity of 8.0 km/h (0% of inclination), progressive increments, a final velocity of 18 km/h (2% de inclination). The duration was equal to 10 minutes or until voluntary exhaustion.
Total Time Reaching on Maximal Test (tVO2max)Pre and post 14 weeks/46 sessions of trainingThe criterion for determining the total time reaching in maximal VO2 test was associated with the time immediately preceding heart rate shown a reduction of five or more beats.

Secondary

MeasureTime frameDescription
Blood Lactate on Submaximal TestPre; during (retest I 0-6weeks; retest II 0-10 weeks) and post 14 weeks/46 sessions training: rest (5-min sitting; before start the test); 1-3-5 minutes immediately after the end of the test (on sitting position).Capillary blood samples (25 µl) were obtained from the finger of each subject during all tests and the \[La\] were measured using an (Accutrend®Plus Roche Diagnostics Gesellschaft mit beschränkter Haftung , Mannheim, Germany). The measuring range was 0.8-22 mM. The sample is collecting (Accu-Chek® Softclix) and first applied to a coded yellow test strip (Accutrend Blood Measure-Roche) with a reagent chemical substance. Blood was added to the strip by letting it drip from a finger; in accordance with the instrument's instructions we never let the finger touch the strip's pad in order to exclude any possible interference due to the sweat.
Submaximal Velocity [Vsub]Pre; during (retest I 0-6weeks; retest II 0-10 weeks) and post 14 weeks/46sessions of trainingSubmaximal tests were done at the same treadmill (Treadmill® TR9100HR, Life Fitness, USA) as training.Before the test, all subjects should be able to do it at moderate-high intensity. The test began with three minutes of progressive warm-up. During the first minute, the subject maintains a light level; during the second and third minutes of the warm-up, the intensity was moderate. Starting from the fourth minute, the subject should be able to maintain a velocity for the next seven to ten minutes. This load can be adjusted as required, through verbal communication between the subject and the evaluator. The test finishes at the end of 10 minutes. The test velocity should be clearly constant at the end of the test. Values of velocity were monitored and recorded at the end of each minute, e.g. 10 seconds before ending each measured minute, and the last measurement were at the end of the 10 minutes. The objective of this procedure was to identify the value of that speed has stabilized.
Rate of Perceived Exertion (RPE) on Submaximal TestPre; during (retest I 0-6weeks; retest II 0-10 weeks) and post 14 weeks/46sessions trainingThe RPE was collected at submaximal test (see description of test on outcome measure HR at submaximal test). Relative to overall feelings were collected by Category Ratio Scale (CR10) during the last 15 s of each stage using the Borg category (0 - 10) scale. Instructions for RPE were that 0 corresponds to rest, and 9 - 10 corresponds to maximal exertion. This verbal procedure was explained before initiating exercise.
Heart Rate on Submaximal TestPre; during (retest I 0-6weeks; retest II 0-10 weeks) and post 14 weeks/46sessions training: rest (5-min sitting; before start the test); maximal during the test (maxHRsub); 60s-120s immediately after the end of the test (on sitting position).Submaximal tests were done at the same treadmill (Treadmill® TR9100HR, Life Fitness, USA) as training.Before the test, all subjects should be able to do it at moderate-high intensity. The test began with three minutes of progressive warm-up. During the first minute, the subject maintains a light level; during the second and third minutes of the warm-up, the intensity was moderate. Starting from the fourth minute, the subject should be able to maintain a velocity for the next seven to ten minutes. This load can be adjusted as required, through verbal communication between the subject and the evaluator. The test finishes at the end of 10 minutes.The test velocity should be clearly constant at the end of the test. Heart rate were monitored and recorded at the end of each minute, e.g. 10 seconds before ending each measured minute, and the last measurement were at the end of the 10 minutes. The objective of this procedure was to identify the HR values for training intensities.

Countries

Brazil

Participant flow

Recruitment details

Participants were randomly assigned on August 2012 to either an interval,continuous training or control group from Sept to Dec. Tests and training were performed in a controlled laboratory condition.Tests were each separated by 24-48 h.One week before baseline they did a familiarization to submaximal test and all physiological measures.

Pre-assignment details

Due to factors outside the present study, three individuals were removed from the program. Two individuals during maximal exercise test (VO2) showed clinical impairment test being interrupted by the doctor and the third individual presented a plantar fasciitis in the early familiarization.

Participants by arm

ArmCount
Interval
The running training for interval group were performed on a treadmill for a period of 14 weeks, with a frequency of three times a week, lasting 20-minutes per session thus completing 46 sessions of training. The intensity and volume of training both were adapted according to the recommendations of the American College of Sports Medicine. The interval training group intensities ranged between 84-87% HRVO2peak/HRmax-maximal heart rate (vigorous intensity), 88-93%HRVO2peak/HRmax (near maximum intensity) and 94-99% HRVO2peak/HRmax (maximum intensity).
13
Continuous
The running training for continuous group were performed on a treadmill for a period of 14 weeks, with a frequency of three times a week, lasting 20-minutes per session thus completing 46 sessions of training. The intensity and volume of training both were adapted according to the recommendations of the American College of Sports Medicine. The continuous group ran at an intensity of \ 87%HRVO2peak/HRmax.
11
Control
The control group did not do the running training program. Control did their normal physical activities.
8
Total32

Baseline characteristics

CharacteristicContinuousControlIntervalTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
11 Participants8 Participants13 Participants32 Participants
Age, Continuous30.5 years
STANDARD_DEVIATION 1
29.1 years
STANDARD_DEVIATION 4.4
30.2 years
STANDARD_DEVIATION 0.8
30 years
STANDARD_DEVIATION 2
Region of Enrollment
Brazil
11 participants8 participants13 participants32 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants0 Participants
Sex: Female, Male
Male
11 Participants8 Participants13 Participants32 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 130 / 110 / 8
serious
Total, serious adverse events
0 / 130 / 110 / 8

Outcome results

Primary

Absolute Maximal Oxygen Uptake

The absolute maximal oxygen uptake was taken by individual connected to a metabolic gas analyzer (VO-2000, Aerosport, Medgraphics, St. Paul, Minnesota) through which the gas samples were collected and measured each 10 seconds during the test. The participants were submitted to a ramp protocol with an initial velocity of 8.0 km/h (0% of inclination), progressive increments, a final velocity of 18 km/h (2% de inclination). The duration was equal to 10 minutes or until voluntary exhaustion.

Time frame: Pre and post 14 weeks

ArmMeasureGroupValue (MEAN)Dispersion
IntervalAbsolute Maximal Oxygen UptakePre VO23.67 L/minStandard Deviation 0.6
IntervalAbsolute Maximal Oxygen UptakePost VO24.0 L/minStandard Deviation 0.6
ContinuousAbsolute Maximal Oxygen UptakePre VO23.89 L/minStandard Deviation 0.3
ContinuousAbsolute Maximal Oxygen UptakePost VO24.0 L/minStandard Deviation 0.3
ControlAbsolute Maximal Oxygen UptakePre VO23.80 L/minStandard Deviation 0.5
ControlAbsolute Maximal Oxygen UptakePost VO23.7 L/minStandard Deviation 0.4
Primary

Blood Lactate Concentrations on Maximal Test

Capillary blood samples (25 µl) were obtained from the finger of each subject during all tests and the \[La\] were measured using an (Accutrend®Plus Roche Diagnostics Gesellschaft mit beschränkter Haftung , Mannheim, Germany). The measuring range was 0.8-22 millimole (mM). The sample is collecting (Accu-Chek® Softclix) and first applied to a coded yellow test strip (Accutrend Blood measure-Roche) with a reagent chemical substance. Blood was added to the strip by letting it drip from a finger; in accordance with the instrument's instructions. The finger never touched the strip's pad in order to exclude any possible interference due to the sweat. All \[La\] were collected by a single, experienced investigator.

Time frame: Pre and post 14 weeks/46sessions on rest (5 min sitting position; before start the test); 1-3-5 min immediately after the end of the test (on sitting position).

ArmMeasureGroupValue (MEAN)Dispersion
IntervalBlood Lactate Concentrations on Maximal Testpre [La] 1-min12.03 mmol*L^-1Standard Deviation 2.89
IntervalBlood Lactate Concentrations on Maximal Testpre [La] 5-min9.74 mmol*L^-1Standard Deviation 3.4
IntervalBlood Lactate Concentrations on Maximal Testpost [La] 1-min13.14 mmol*L^-1Standard Deviation 2.57
IntervalBlood Lactate Concentrations on Maximal Testpre [La] 3-min11.42 mmol*L^-1Standard Deviation 2.23
IntervalBlood Lactate Concentrations on Maximal Testpost [La] 3-min12.66 mmol*L^-1Standard Deviation 2.5
IntervalBlood Lactate Concentrations on Maximal Testpost [La] 5-min13 mmol*L^-1Standard Deviation 2.58
IntervalBlood Lactate Concentrations on Maximal Testpre [La] rest2.55 mmol*L^-1Standard Deviation 0.38
IntervalBlood Lactate Concentrations on Maximal Testpost [La] rest2.73 mmol*L^-1Standard Deviation 0.39
ContinuousBlood Lactate Concentrations on Maximal Testpre [La] 1-min12.21 mmol*L^-1Standard Deviation 2.49
ContinuousBlood Lactate Concentrations on Maximal Testpost [La] 1-min13.23 mmol*L^-1Standard Deviation 1.57
ContinuousBlood Lactate Concentrations on Maximal Testpre [La] 3-min11.97 mmol*L^-1Standard Deviation 2.9
ContinuousBlood Lactate Concentrations on Maximal Testpre [La] 5-min11.5 mmol*L^-1Standard Deviation 2.74
ContinuousBlood Lactate Concentrations on Maximal Testpost [La] 5-min12.9 mmol*L^-1Standard Deviation 1.49
ContinuousBlood Lactate Concentrations on Maximal Testpost [La] 3-min12.88 mmol*L^-1Standard Deviation 1.65
ContinuousBlood Lactate Concentrations on Maximal Testpre [La] rest2.40 mmol*L^-1Standard Deviation 0.2
ContinuousBlood Lactate Concentrations on Maximal Testpost [La] rest2.29 mmol*L^-1Standard Deviation 0.45
ControlBlood Lactate Concentrations on Maximal Testpre [La] 1-min13.41 mmol*L^-1Standard Deviation 1.54
ControlBlood Lactate Concentrations on Maximal Testpre [La] 5-min12.26 mmol*L^-1Standard Deviation 1.74
ControlBlood Lactate Concentrations on Maximal Testpost [La] rest2.68 mmol*L^-1Standard Deviation 0.23
ControlBlood Lactate Concentrations on Maximal Testpre [La] rest2.36 mmol*L^-1Standard Deviation 0.23
ControlBlood Lactate Concentrations on Maximal Testpost [La] 5-min13.45 mmol*L^-1Standard Deviation 1.4
ControlBlood Lactate Concentrations on Maximal Testpre [La] 3-min12.88 mmol*L^-1Standard Deviation 1.56
ControlBlood Lactate Concentrations on Maximal Testpost [La] 1-min13.30 mmol*L^-1Standard Deviation 1.39
ControlBlood Lactate Concentrations on Maximal Testpost [La] 3-min13.44 mmol*L^-1Standard Deviation 1.56
Primary

Body Mass (BM)

To measure body mass Filizola scales with a stadiometer was used.

Time frame: Body Mass was collected pre and post training

ArmMeasureGroupValue (MEAN)Dispersion
IntervalBody Mass (BM)pre BM77.6 kgStandard Deviation 13.5
IntervalBody Mass (BM)post BM77.5 kgStandard Deviation 13.7
ContinuousBody Mass (BM)pre BM76.6 kgStandard Deviation 3.7
ContinuousBody Mass (BM)post BM76.1 kgStandard Deviation 4.4
ControlBody Mass (BM)pre BM76.4 kgStandard Deviation 10.9
ControlBody Mass (BM)post BM76.0 kgStandard Deviation 11.1
Primary

Fat Mass (%)

The subjects underwent a set of anthropometric assessments, which followed the norms of the International Society for Advancement of Kinanthropometry. The fat mass was calculated by percentage using the equation proposed by Jackson and Pollock (1978) from seven skinfold measurement. To measure the skinfolds, a Sanny Professional Skinfold Caliper was used.

Time frame: Pre and post 14 weeks/46 sessions of training

ArmMeasureGroupValue (MEAN)Dispersion
IntervalFat Mass (%)pre14.3 Fat Mass %Standard Deviation 6
IntervalFat Mass (%)post14.9 Fat Mass %Standard Deviation 5.6
ContinuousFat Mass (%)post13.6 Fat Mass %Standard Deviation 5.1
ContinuousFat Mass (%)pre11.9 Fat Mass %Standard Deviation 3.9
ControlFat Mass (%)post13.4 Fat Mass %Standard Deviation 4.7
ControlFat Mass (%)pre12.5 Fat Mass %Standard Deviation 4.9
Primary

Heart Rate on Maximal Test

The HR was collected pre and post training on maximal VO2 test. Initially, with the individual on the treadmill (Inbrasport Master Super, Porto Alegre, Brazil), electrodes (Micromed) were placed at the manubrium, right and left iliac crest for measured heart rate (HR) (derivation CM5) and were connected to an electromyography equipment (Micromed®). HR values were visualized through Elite software (Micromed Biotechnology, Brasilia, Brazil).

Time frame: Pre and post 14 weeks at rest (5 min sitting; before start the test), during the test (to determine max), and 60s and 120s immediately after the end of the test (on sitting position)

ArmMeasureGroupValue (MEAN)Dispersion
IntervalHeart Rate on Maximal Testpre HR max185.3 bpmStandard Deviation 11.2
IntervalHeart Rate on Maximal Testpre HR rest68.8 bpmStandard Deviation 9.8
IntervalHeart Rate on Maximal Testpost HR max187.0 bpmStandard Deviation 10.6
IntervalHeart Rate on Maximal Testpost HR 120s108.7 bpmStandard Deviation 11.1
IntervalHeart Rate on Maximal Testpost HR rest59.3 bpmStandard Deviation 8.6
IntervalHeart Rate on Maximal Testpre HR 60s122.5 bpmStandard Deviation 19.8
IntervalHeart Rate on Maximal Testpre HR 120s110.3 bpmStandard Deviation 14.4
IntervalHeart Rate on Maximal Testpost HR 60s120.9 bpmStandard Deviation 10.5
ContinuousHeart Rate on Maximal Testpost HR rest57.2 bpmStandard Deviation 2.1
ContinuousHeart Rate on Maximal Testpost HR 60s117.5 bpmStandard Deviation 13.3
ContinuousHeart Rate on Maximal Testpre HR rest67.3 bpmStandard Deviation 9.6
ContinuousHeart Rate on Maximal Testpre HR 120s107.0 bpmStandard Deviation 9.4
ContinuousHeart Rate on Maximal Testpost HR 120s108.4 bpmStandard Deviation 13.7
ContinuousHeart Rate on Maximal Testpre HR max183.5 bpmStandard Deviation 9.4
ContinuousHeart Rate on Maximal Testpost HR max185.3 bpmStandard Deviation 10.5
ContinuousHeart Rate on Maximal Testpre HR 60s116.3 bpmStandard Deviation 10
ControlHeart Rate on Maximal Testpost HR max191.0 bpmStandard Deviation 8.5
ControlHeart Rate on Maximal Testpre HR rest65.8 bpmStandard Deviation 8.2
ControlHeart Rate on Maximal Testpost HR rest64.4 bpmStandard Deviation 10.3
ControlHeart Rate on Maximal Testpre HR max190.5 bpmStandard Deviation 6
ControlHeart Rate on Maximal Testpost HR 120s112.3 bpmStandard Deviation 13.8
ControlHeart Rate on Maximal Testpre HR 60s122.9 bpmStandard Deviation 22.8
ControlHeart Rate on Maximal Testpost HR 60s123.0 bpmStandard Deviation 15.3
ControlHeart Rate on Maximal Testpre HR 120s111.6 bpmStandard Deviation 18
Primary

Rate of Perceived Exertion (RPE) on Maximal Test

The RPE was collected at maximal test (see description of test on outcome measure Maximal Oxygen Uptake). Relative to overall feelings were collected by Category Ratio Scale (CR10) during the last 15 s of each stage using the Borg category (0 - 10) scale. Instructions for RPE were that 0 corresponds to rest, and 9 - 10 corresponds to maximal exertion. This verbal procedure was explained before initiating exercise.

Time frame: Pre and post 14 weeks/46 sessions of training

ArmMeasureGroupValue (MEAN)Dispersion
IntervalRate of Perceived Exertion (RPE) on Maximal Testpre RPE8.9 units on a scaleStandard Deviation 0.9
IntervalRate of Perceived Exertion (RPE) on Maximal Testpost RPE8.8 units on a scaleStandard Deviation 1.5
ContinuousRate of Perceived Exertion (RPE) on Maximal Testpost RPE9.0 units on a scaleStandard Deviation 1.3
ContinuousRate of Perceived Exertion (RPE) on Maximal Testpre RPE9.5 units on a scaleStandard Deviation 0.9
ControlRate of Perceived Exertion (RPE) on Maximal Testpre RPE9.2 units on a scaleStandard Deviation 1
ControlRate of Perceived Exertion (RPE) on Maximal Testpost RPE9.0 units on a scaleStandard Deviation 0.9
Primary

Relative Maximal Oxygen Uptake

The relative maximal oxygen uptake was taken by individual connected to a metabolic gas analyzer (VO-2000, Aerosport, Medgraphics, St. Paul, Minnesota) through which the gas samples were collected and measured each 10 seconds during the test. The participants were submitted to a ramp protocol with an initial velocity of 8.0 km/h (0% of inclination), progressive increments, a final velocity of 18 km/h (2% de inclination). The duration was equal to 10 minutes or until voluntary exhaustion.

Time frame: Pre and post 14 weeks

ArmMeasureGroupValue (MEAN)Dispersion
IntervalRelative Maximal Oxygen UptakePre VO247.8 mL/(kg*min)Standard Deviation 6.3
IntervalRelative Maximal Oxygen UptakePost VO251.7 mL/(kg*min)Standard Deviation 5.9
ContinuousRelative Maximal Oxygen UptakePost VO252.8 mL/(kg*min)Standard Deviation 5.1
ContinuousRelative Maximal Oxygen UptakePre VO250.9 mL/(kg*min)Standard Deviation 6
ControlRelative Maximal Oxygen UptakePost VO249.4 mL/(kg*min)Standard Deviation 6.4
ControlRelative Maximal Oxygen UptakePre VO249.7 mL/(kg*min)Standard Deviation 5.6
Comparison: For pre-post training variables data were expressed as mean and standard deviation. Heart Rate and Blood Lactate, were by three-way ANOVA (Measure x Group x Time) with repeated measures for the factors Measure and Time. The variables absolute and relative VO2, tVO2, Body Fat, Body Mass, RPE, were made two-way ANOVAs (Group x Measure) with repeated measures on the factor Measure. Where the ANOVA was significant, the Tukey-Kramer as post-hoc was used.p-value: <0.05ANOVA
Comparison: For pre; during (retest I 0-6weeks; retest II 0-10 weeks) and post training data were expressed as mean and standard deviation. HR and \[La\], were by three-way ANOVA (Measure x Group x Time) with repeated measures for the factors Measure and Time. The variables RPE, Velocity were made two-way ANOVAs (Group x Measure) with repeated measures on the factor Measure. Where the ANOVA was significant, the Tukey-Kramer as post-hoc was used. Control didn't do submaximal test for training intensities.p-value: <0.05ANOVA
Primary

Total Time Reaching on Maximal Test (tVO2max)

The criterion for determining the total time reaching in maximal VO2 test was associated with the time immediately preceding heart rate shown a reduction of five or more beats.

Time frame: Pre and post 14 weeks/46 sessions of training

ArmMeasureGroupValue (MEAN)Dispersion
IntervalTotal Time Reaching on Maximal Test (tVO2max)pre tVO2max9.2 minutesStandard Deviation 0.8
IntervalTotal Time Reaching on Maximal Test (tVO2max)post tVO2max10.2 minutesStandard Deviation 0.7
ContinuousTotal Time Reaching on Maximal Test (tVO2max)pre tVO2max10.5 minutesStandard Deviation 1.1
ContinuousTotal Time Reaching on Maximal Test (tVO2max)post tVO2max10.7 minutesStandard Deviation 1
ControlTotal Time Reaching on Maximal Test (tVO2max)pre tVO2max9.6 minutesStandard Deviation 1.8
ControlTotal Time Reaching on Maximal Test (tVO2max)post tVO2max9.5 minutesStandard Deviation 1.9
Secondary

Blood Lactate on Submaximal Test

Capillary blood samples (25 µl) were obtained from the finger of each subject during all tests and the \[La\] were measured using an (Accutrend®Plus Roche Diagnostics Gesellschaft mit beschränkter Haftung , Mannheim, Germany). The measuring range was 0.8-22 mM. The sample is collecting (Accu-Chek® Softclix) and first applied to a coded yellow test strip (Accutrend Blood Measure-Roche) with a reagent chemical substance. Blood was added to the strip by letting it drip from a finger; in accordance with the instrument's instructions we never let the finger touch the strip's pad in order to exclude any possible interference due to the sweat.

Time frame: Pre; during (retest I 0-6weeks; retest II 0-10 weeks) and post 14 weeks/46 sessions training: rest (5-min sitting; before start the test); 1-3-5 minutes immediately after the end of the test (on sitting position).

Population: The control group didn't do the submaximal test because it was done to determine and adjusted the HR training intensities and also collected \[La\] on rest and after submaximal effort during 14 weeks of training.

ArmMeasureGroupValue (MEAN)Dispersion
IntervalBlood Lactate on Submaximal Testpost [La] rest2.81 mmol*L^-1Standard Deviation 0.39
IntervalBlood Lactate on Submaximal Testpost [La] 3-min7.52 mmol*L^-1Standard Deviation 2.25
IntervalBlood Lactate on Submaximal Testpost [La] 1-min8.12 mmol*L^-1Standard Deviation 2.37
IntervalBlood Lactate on Submaximal Testpre [La] 5-min5.85 mmol*L^-1Standard Deviation 2.33
IntervalBlood Lactate on Submaximal Testretest I [La] 1-min7.52 mmol*L^-1Standard Deviation 1.81
IntervalBlood Lactate on Submaximal Testretest I [La] 5-min5.80 mmol*L^-1Standard Deviation 1.74
IntervalBlood Lactate on Submaximal Testpre [La] 3-min6.96 mmol*L^-1Standard Deviation 2.43
IntervalBlood Lactate on Submaximal Testretest II [La] 5-min6.91 mmol*L^-1Standard Deviation 2.34
IntervalBlood Lactate on Submaximal Testpre [La] 1-min7.41 mmol*L^-1Standard Deviation 2.28
IntervalBlood Lactate on Submaximal Testpost [La] 5-min6.79 mmol*L^-1Standard Deviation 2.03
IntervalBlood Lactate on Submaximal Testretest I [La] 3-min6.52 mmol*L^-1Standard Deviation 1.93
IntervalBlood Lactate on Submaximal Testpre [La] rest2.59 mmol*L^-1Standard Deviation 0.33
IntervalBlood Lactate on Submaximal Testretest II [La] 1-min8.14 mmol*L^-1Standard Deviation 2.34
IntervalBlood Lactate on Submaximal Testretest I [La] rest2.66 mmol*L^-1Standard Deviation 0.57
IntervalBlood Lactate on Submaximal Testretest II [La] 3-min7.50 mmol*L^-1Standard Deviation 2.23
IntervalBlood Lactate on Submaximal Testretest II [La] rest2.42 mmol*L^-1Standard Deviation 0.4
ContinuousBlood Lactate on Submaximal Testretest II [La] 3-min7.00 mmol*L^-1Standard Deviation 1.39
ContinuousBlood Lactate on Submaximal Testpost [La] rest2.56 mmol*L^-1Standard Deviation 0.5
ContinuousBlood Lactate on Submaximal Testpre [La] 1-min9.39 mmol*L^-1Standard Deviation 2.3
ContinuousBlood Lactate on Submaximal Testretest I [La] 1-min6.94 mmol*L^-1Standard Deviation 1.75
ContinuousBlood Lactate on Submaximal Testretest II [La] 1-min7.89 mmol*L^-1Standard Deviation 1.5
ContinuousBlood Lactate on Submaximal Testpost [La] 1-min7.69 mmol*L^-1Standard Deviation 2.1
ContinuousBlood Lactate on Submaximal Testpre [La] 3-min8.80 mmol*L^-1Standard Deviation 2.48
ContinuousBlood Lactate on Submaximal Testretest I [La] 3-min5.65 mmol*L^-1Standard Deviation 1.05
ContinuousBlood Lactate on Submaximal Testretest II [La] rest2.25 mmol*L^-1Standard Deviation 0.44
ContinuousBlood Lactate on Submaximal Testpost [La] 3-min7.07 mmol*L^-1Standard Deviation 2.02
ContinuousBlood Lactate on Submaximal Testpre [La] 5-min7.21 mmol*L^-1Standard Deviation 3.18
ContinuousBlood Lactate on Submaximal Testretest I [La] 5-min5.22 mmol*L^-1Standard Deviation 1.35
ContinuousBlood Lactate on Submaximal Testretest II [La] 5-min6.49 mmol*L^-1Standard Deviation 1.27
ContinuousBlood Lactate on Submaximal Testpost [La] 5-min6.49 mmol*L^-1Standard Deviation 2.03
ContinuousBlood Lactate on Submaximal Testpre [La] rest2.40 mmol*L^-1Standard Deviation 0.22
ContinuousBlood Lactate on Submaximal Testretest I [La] rest2.45 mmol*L^-1Standard Deviation 0.39
Secondary

Heart Rate on Submaximal Test

Submaximal tests were done at the same treadmill (Treadmill® TR9100HR, Life Fitness, USA) as training.Before the test, all subjects should be able to do it at moderate-high intensity. The test began with three minutes of progressive warm-up. During the first minute, the subject maintains a light level; during the second and third minutes of the warm-up, the intensity was moderate. Starting from the fourth minute, the subject should be able to maintain a velocity for the next seven to ten minutes. This load can be adjusted as required, through verbal communication between the subject and the evaluator. The test finishes at the end of 10 minutes.The test velocity should be clearly constant at the end of the test. Heart rate were monitored and recorded at the end of each minute, e.g. 10 seconds before ending each measured minute, and the last measurement were at the end of the 10 minutes. The objective of this procedure was to identify the HR values for training intensities.

Time frame: Pre; during (retest I 0-6weeks; retest II 0-10 weeks) and post 14 weeks/46sessions training: rest (5-min sitting; before start the test); maximal during the test (maxHRsub); 60s-120s immediately after the end of the test (on sitting position).

Population: The control group didn't do the submaximal test because it was done to determine and adjusted the training intensities during the 14 weeks.

ArmMeasureGroupValue (MEAN)Dispersion
IntervalHeart Rate on Submaximal Testpost HR rest59.8 bpmStandard Deviation 8.8
IntervalHeart Rate on Submaximal Testretest II maxHRsub174.3 bpmStandard Deviation 9.9
IntervalHeart Rate on Submaximal Testpre maxHRsub174.8 bpmStandard Deviation 9.6
IntervalHeart Rate on Submaximal Testpre HR 120s98.9 bpmStandard Deviation 14.8
IntervalHeart Rate on Submaximal Testretest II HR rest61.2 bpmStandard Deviation 8.8
IntervalHeart Rate on Submaximal Testpre HR rest63.9 bpmStandard Deviation 6.4
IntervalHeart Rate on Submaximal Testretest II HR 120s91.9 bpmStandard Deviation 17.4
IntervalHeart Rate on Submaximal Testpost HR 120s93.8 bpmStandard Deviation 11.9
IntervalHeart Rate on Submaximal Testpre HR 60s116.2 bpmStandard Deviation 16.8
IntervalHeart Rate on Submaximal Testretest I HR rest60.8 bpmStandard Deviation 9.7
IntervalHeart Rate on Submaximal Testretest I HR 120s90.5 bpmStandard Deviation 13.4
IntervalHeart Rate on Submaximal Testpost HR 60s103.0 bpmStandard Deviation 11.3
IntervalHeart Rate on Submaximal Testretest I HR 60s106.5 bpmStandard Deviation 14.1
IntervalHeart Rate on Submaximal Testretest I maxHRsub173.3 bpmStandard Deviation 10.5
IntervalHeart Rate on Submaximal Testretest II HR 60s105.5 bpmStandard Deviation 14
IntervalHeart Rate on Submaximal Testpost maxHRsub174.3 bpmStandard Deviation 7.6
ContinuousHeart Rate on Submaximal Testretest II HR 60s99.8 bpmStandard Deviation 14.4
ContinuousHeart Rate on Submaximal Testretest II HR 120s90.8 bpmStandard Deviation 12.3
ContinuousHeart Rate on Submaximal Testpost HR 120s89.9 bpmStandard Deviation 9.3
ContinuousHeart Rate on Submaximal Testpost maxHRsub170.1 bpmStandard Deviation 9.7
ContinuousHeart Rate on Submaximal Testpre HR rest67.2 bpmStandard Deviation 10.8
ContinuousHeart Rate on Submaximal Testretest I HR rest64.0 bpmStandard Deviation 8.5
ContinuousHeart Rate on Submaximal Testretest II HR rest59.6 bpmStandard Deviation 10.7
ContinuousHeart Rate on Submaximal Testpost HR rest58.7 bpmStandard Deviation 2.6
ContinuousHeart Rate on Submaximal Testpre maxHRsub175.0 bpmStandard Deviation 8.3
ContinuousHeart Rate on Submaximal Testretest II maxHRsub173.2 bpmStandard Deviation 10
ContinuousHeart Rate on Submaximal Testretest I maxHRsub169.8 bpmStandard Deviation 10.3
ContinuousHeart Rate on Submaximal Testpost HR 60s100.7 bpmStandard Deviation 12.7
ContinuousHeart Rate on Submaximal Testpre HR 120s102.3 bpmStandard Deviation 9.2
ContinuousHeart Rate on Submaximal Testpre HR 60s116.9 bpmStandard Deviation 12.5
ContinuousHeart Rate on Submaximal Testretest I HR 120s87.5 bpmStandard Deviation 10.5
ContinuousHeart Rate on Submaximal Testretest I HR 60s98.3 bpmStandard Deviation 11.6
Secondary

Rate of Perceived Exertion (RPE) on Submaximal Test

The RPE was collected at submaximal test (see description of test on outcome measure HR at submaximal test). Relative to overall feelings were collected by Category Ratio Scale (CR10) during the last 15 s of each stage using the Borg category (0 - 10) scale. Instructions for RPE were that 0 corresponds to rest, and 9 - 10 corresponds to maximal exertion. This verbal procedure was explained before initiating exercise.

Time frame: Pre; during (retest I 0-6weeks; retest II 0-10 weeks) and post 14 weeks/46sessions training

Population: The control group didn't do the submaximal test because it was done only for determine and adjusted the training intensities.

ArmMeasureGroupValue (MEAN)Dispersion
IntervalRate of Perceived Exertion (RPE) on Submaximal Testpre RPE6 units on a scaleStandard Deviation 1
IntervalRate of Perceived Exertion (RPE) on Submaximal Testretest I RPE6 units on a scaleStandard Deviation 1
IntervalRate of Perceived Exertion (RPE) on Submaximal Testretest II RPE6 units on a scaleStandard Deviation 2
IntervalRate of Perceived Exertion (RPE) on Submaximal Testpost RPE7 units on a scaleStandard Deviation 2
ContinuousRate of Perceived Exertion (RPE) on Submaximal Testretest I RPE5 units on a scaleStandard Deviation 1
ContinuousRate of Perceived Exertion (RPE) on Submaximal Testpre RPE6 units on a scaleStandard Deviation 2
ContinuousRate of Perceived Exertion (RPE) on Submaximal Testpost RPE7 units on a scaleStandard Deviation 1
ContinuousRate of Perceived Exertion (RPE) on Submaximal Testretest II RPE6 units on a scaleStandard Deviation 2
Secondary

Submaximal Velocity [Vsub]

Submaximal tests were done at the same treadmill (Treadmill® TR9100HR, Life Fitness, USA) as training.Before the test, all subjects should be able to do it at moderate-high intensity. The test began with three minutes of progressive warm-up. During the first minute, the subject maintains a light level; during the second and third minutes of the warm-up, the intensity was moderate. Starting from the fourth minute, the subject should be able to maintain a velocity for the next seven to ten minutes. This load can be adjusted as required, through verbal communication between the subject and the evaluator. The test finishes at the end of 10 minutes. The test velocity should be clearly constant at the end of the test. Values of velocity were monitored and recorded at the end of each minute, e.g. 10 seconds before ending each measured minute, and the last measurement were at the end of the 10 minutes. The objective of this procedure was to identify the value of that speed has stabilized.

Time frame: Pre; during (retest I 0-6weeks; retest II 0-10 weeks) and post 14 weeks/46sessions of training

Population: The control group didn't do the submaximal test because it was done to determine and adjusted the HR training intensities and also collected \[Vsub\] during submaximal effort.

ArmMeasureGroupValue (MEAN)Dispersion
IntervalSubmaximal Velocity [Vsub]pre [Vsub]13.2 km/hStandard Deviation 2
IntervalSubmaximal Velocity [Vsub]retest I [Vsub]13.4 km/hStandard Deviation 0.8
IntervalSubmaximal Velocity [Vsub]post [Vsub]13.9 km/hStandard Deviation 0.8
IntervalSubmaximal Velocity [Vsub]retest II [Vsub]13.9 km/hStandard Deviation 0.6
ContinuousSubmaximal Velocity [Vsub]post [Vsub]13.9 km/hStandard Deviation 0.9
ContinuousSubmaximal Velocity [Vsub]retest I [Vsub]13.7 km/hStandard Deviation 1.6
ContinuousSubmaximal Velocity [Vsub]retest II [Vsub]14.4 km/hStandard Deviation 1.1
ContinuousSubmaximal Velocity [Vsub]pre [Vsub]13.9 km/hStandard Deviation 1.4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026